GIANNOTTA, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 103
EU - Europa 102
AS - Asia 54
AF - Africa 6
OC - Oceania 3
SA - Sud America 2
Totale 270
Nazione #
US - Stati Uniti d'America 98
IT - Italia 73
SG - Singapore 31
GB - Regno Unito 7
ID - Indonesia 7
IR - Iran 6
CA - Canada 5
FR - Francia 4
IE - Irlanda 4
IN - India 3
NO - Norvegia 3
CN - Cina 2
CO - Colombia 2
DE - Germania 2
EG - Egitto 2
FI - Finlandia 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AU - Australia 1
BE - Belgio 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IL - Israele 1
MA - Marocco 1
NL - Olanda 1
PT - Portogallo 1
SE - Svezia 1
TG - Togo 1
TR - Turchia 1
ZW - Zimbabwe 1
Totale 270
Città #
Turin 35
Singapore 24
Santa Clara 20
Ashburn 7
Columbus 7
Jakarta 7
Casalecchio di Reno 5
Dublin 4
Florence 4
La Habra 4
Los Angeles 4
New Malden 4
Palermo 4
Paris 4
Rome 4
Edmonton 3
El Monte 3
Milan 3
New York 3
Alexandria 2
Ambler 2
Auckland 2
Baldissero d'Alba 2
Bogotá 2
Boston 2
Debrecen 2
Harringay 2
Lappeenranta 2
Pune 2
Tehran 2
Abidjan 1
Birmingham 1
Brussels 1
Casablanca 1
Central 1
Dallas 1
Fremont 1
Fubine 1
Guangzhou 1
Guwahati 1
Hadera 1
Harare 1
Indianapolis 1
La Jolla 1
Las Vegas 1
Lomé 1
Malo 1
Mannheim 1
Melbourne 1
Modena 1
Nepean 1
New Orleans 1
Noto 1
Nyköping 1
Olomouc 1
Oslo 1
Ostenfeld 1
Parsippany 1
Pedrengo 1
Toronto 1
Vezirkopru 1
Washington 1
Totale 203
Nome #
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells 103
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status 43
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma 35
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT 26
Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? 26
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA 18
MULTIFACETED IMMUNE CHECKPOINT EXPRESSION AND SENESCENT MARKERS IMPAIRS BONE MARROW Vγ9Vδ2 T-CELL FUNCTION IN MULTIPLE MYELOMA PATIENTS 16
Untangling the immune suppressive network to accelerate the roadmap for a cure in human myeloma 10
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment 9
Totale 286
Categoria #
all - tutte 1.426
article - articoli 0
book - libri 0
conference - conferenze 162
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.588


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023129 0 0 0 0 0 5 30 22 21 29 16 6
2023/202455 6 9 8 4 4 9 3 0 0 2 3 7
2024/2025102 10 13 17 22 40 0 0 0 0 0 0 0
Totale 286